Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx Signs Middle East, North Africa Distribution Deal With BPI

NEW YORK (GenomeWeb) – Lebanese pharmaceutical product manufacturer BPI has signed an agreement to distribute IncellDx's portfolio of immune-oncology and oncology diagnostic products in the Middle East and North Africa.

Included in the deal are IncellDx's OncoTect single-cell assay for quantifying PD-L1 on tumor cells and immune cell subtypes; its single-cell assay for HPV E6/E7 mRNA detection in cervical samples; and its IncellPrep single-cell preparation kit for solid tissues including tumors.

Additional terms were not disclosed.

IncellDx signed a number of distribution deals for its products recently including one with Premas Life Sciences covering India and one with GIMDx covering China. And earlier this year, IncellDx partnered with Celsee on the commercialization of several diagnostic products including a 20-marker lung cancer genomics and proteomics panel and a cell-based non-invasive prenatal testing assay.